Cosopt and retinal disorder Patient Reports February 11, 2012

Cosopt Side Effects Report #5243413-0
Cosopt side effect was reported by a Physician from KOREA, REPUBLIC OF on Jan 24, 2007. Female patient, 35 years of age, was diagnosed with open angle glaucoma and was treated with Cosopt. After drug was administered, patient experienced the following side effects: disease progression, retinal disorder , scotoma, visual field defect. Cosopt dosage: unknown. During the same period patient was treated with BRIMONIDINE TARTRATE, XALATAN. Patient was hospitalized. Patient recovered.

Cosopt Side Effects Report #5737797-4
Cosopt side effect was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2008. Female patient, 75 years of age, was diagnosed with glaucoma  and was treated with Cosopt. After drug was administered, patient experienced the following side effects: eye swelling, intraocular pressure increased, retinal disorder , retinal vein occlusion, retinal vein thrombosis, retinitis, visual acuity reduced. Cosopt dosage: unknown. During the same period patient was treated with PILOCARPINE, LUMIGAN, ZETIA, PRAVASTATIN, OMEPRAZOLE. Patient recovered.

Cosopt Side Effects Report #5757114-3
Cosopt side effect was reported by a Consumer or non-health professional from UNITED STATES on May 28, 2008. Female patient, 75 years of age, was diagnosed with glaucoma  and was treated with Cosopt. After drug was administered, patient experienced the following side effects: eye swelling, intraocular pressure increased, retinal disorder , retinal vein occlusion, visual acuity reduced. Cosopt dosage: unknown. During the same period patient was treated with PILOCARPINE, LUMIGAN, ZETIA, PRAVASTATIN, OMEPRAZOLE. Patient recovered.

Cosopt Side Effects Report #5243411-7
Cosopt side effect was reported by a Physician from KOREA, REPUBLIC OF on Jan 24, 2007. Female patient, 26 years of age, was diagnosed with developmental glaucoma, open angle glaucoma and was treated with Cosopt. After drug was administered, patient experienced the following side effects: condition aggravated, corneal oedema, intraocular pressure increased, optic nerve cup/disc ratio increased, retinal disorder , vision blurred, visual acuity reduced. Cosopt dosage: unknown. During the same period patient was treated with ALPHAGAN P, ALPHAGAN P, XALATAN. Patient was hospitalized. Patient recovered.